IOL Chemicals and Pharmaceuticals Limited (IOL) has appointed Vikas Vij as the new Chief Executive Officer, with effect from April 3. Vij’s role is expected to aid the company to bolster growth across domestic and international markets by leading IOL’s portfolio enhancement and efficiencies.

Vikas has taken over from Sanjay Chaturvedi.

Vikas comes with a techno-commercial background with a nuanced understanding of Active Pharmaceutical Ingredients (API), Finished Dosage Forms (FDF), Custom Pharmaceutical Services (CRAMS), specialty chemicals, and operations from his previous leadership roles across the pharma value chain.

He was previously associated with Cipla as the Senior Vice President of API and Access Business Units. In his career spanning over 30 years, he has donned various roles in Ranbaxy, GVK Biosciences, Alembic Pharmaceuticals, Sun Pharma, and Apollo Hospitals.

Vikas Gupta – Joint Managing Director of IOL Chemicals and Pharmaceuticals said, “Vikas Vij brings in tremendous capabilities of driving sales and scaling businesses in the pharmaceutical and specialty chemicals domains.  We are confident that his experience across the board will empower us to drive transformational growth for IOL nationally as well as in advanced and emerging markets.”

“It is a great privilege to lead a company that is making a significant impact on people’s lives and on the growth of the Indian Pharmaceutical Industry,” said Vikas.